Cargando…

Radiolabeled antibodies in renal cell carcinoma

Renal cell carcinoma (RCC) is a radio- and chemotherapy resistant tumor, which has a very high morbidity and mortality when metastasized. The current treatment options demonstrate limited efficacy and severe side-effects. Therefore, there is a need for new therapeutic strategies for RCC. As for othe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Formato:	Texto
Lenguaje:	English
Publicado:	e-Med 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151324/ https://www.ncbi.nlm.nih.gov/pubmed/18055291 http://dx.doi.org/10.1102/1470-7330.2007.0025

Ejemplares similares

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2013)

Radiolabelled peptides for oncological diagnosis
por: Laverman, Peter, et al.
Publicado: (2012)

Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
por: Vegt, Erik, et al.
Publicado: (2009)

Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with (111)In-girentuximab
por: van Oostenbrugge, Tim J., et al.
Publicado: (2019)

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
por: Hekman, Marlène C., et al.
Publicado: (2018)

Combination of sunitinib and (177)Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2022)

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
por: Vegt, Erik, et al.
Publicado: (2010)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

Phase I study to assess safety, biodistribution and radiation dosimetry for (89)Zr-girentuximab in patients with renal cell carcinoma
por: Merkx, Robin I. J., et al.
Publicado: (2021)

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
por: Roosenburg, Susan, et al.
Publicado: (2010)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.
por: Steffens, M. G., et al.
Publicado: (1998)

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
por: Melis, Marleen, et al.
Publicado: (2009)

Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015)

Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983)

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
por: Nagao, Kazuhiro, et al.
Publicado: (2018)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016)

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Nuclear medicine imaging and therapy of neuroendocrine tumours
por: Gotthardt, Martin, et al.
Publicado: (2006)

Radiolabeled Peptides and Antibodies in Medicine
por: Kręcisz, Paweł, et al.
Publicado: (2020)

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging
por: Hekman, Marlène C. H., et al.
Publicado: (2017)

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing
por: van den Heuvel, Corina N. A. M., et al.
Publicado: (2019)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

Radiolabeled Antibodies for Cancer Imaging and Therapy
por: Parakh, Sagun, et al.
Publicado: (2022)

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)

Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
por: Uccelli, Licia, et al.
Publicado: (2017)

Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.
por: Begent, R. H., et al.
Publicado: (1989)

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
por: Bleumer, I, et al.
Publicado: (2004)

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model
por: Merkx, Robin I. J., et al.
Publicado: (2022)

(111)In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages
por: Terry, Samantha Y. A., et al.
Publicado: (2015)

Heptadentate chelates for (89)Zr-radiolabelling of monoclonal antibodies
por: Guillou, Amaury, et al.
Publicado: (2022)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
por: Allen, Kevin J. H., et al.
Publicado: (2018)

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
por: Davidson, B. R., et al.
Publicado: (1991)

Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study
por: Engbersen, Richard, et al.
Publicado: (2012)

Contributions of multimodal imaging
por: Oyen, Wim JG
Publicado: (2014)

Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins
por: Dadachova, Ekaterina, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_u88lch5c5caqnao8h7mm3h9nl4